BRINAVESS conc perf 500 mg/25ml flac 25 ml
7680613040032
CH-61304
C01BG11
02.02.0.
1 / 3
google
Details
- Product number
- 6130402
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- vernakalanti hydrochloridum 500 mg corresp. vernakalantum 452.5 mg, acidum citricum monohydricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 25 ml corresp. natrium 78.75 mg.
Articles (1)
Brinavess 500 mg, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | WIZUS |
|
(N/A)
|
452.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
78.75 MG | Substance | HBESI |
Authorization holder
Curatis AG
4410 Liestal
Authorization information
- Swissmedic authorization number
- 61304
- Drug name
- Brinavess, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- C01BG11
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 16/03/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 02.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BRINAVESS conc perf 500 mg/25ml flac 25 ml
- Description (DE)
- BRINAVESS Inf Konz 500 mg/25ml Durchstf 25 ml
- Market launch
- 16/03/2011
- Narcotic (BTM)
- No